News

Cole Schmidtknecht, 22, had insurance but couldn’t afford to refill his asthma inhaler after the cost jumped from $70 to more ...
Jacksonville Journal-Courier on MSN1dOpinion
Commentary: Drug companies, lower the list prices — JC Scott
Congress has singled out pharmacy benefit managers, holding 20 hearings while calling on drug companies only a handful of ...
According to the Center for American Progress, a PBM is a “middleman entity” negotiating contracts between health insurance ...
Every healthcare company claims to be working in the patient's best interest, and yet prices only seem to rise.
Trump asks the drug industry to voluntarily lower prices for U.S. consumers or be subject to a barrage of regulatory actions ...
Every policymaker in America, on both sides of the aisle, wants to lower prescription drug costs. There is a basic ...
President Donald Trump on Monday delivered a blow to the private-sector middlemen who negotiate U.S. drug prices in his executive order on drug pricing, saying he would cut them out as part of a goal ...
PBMs almost never disclose the total discounts they negotiate on specific drugs. So patients' cost-sharing obligations are ...
In January 2025, AARP Public Policy Institute examined average list prices on 25 ... Ubl also said pharmacy benefit managers, which negotiate drug prices on behalf of insurers and patients ...
A February executive order on pharmaceutical price transparency does nothing to change the incentives that keep costs opaque.
The inflated prices in the United States fuel global innovation while foreign health systems get a free ride.” ...